SIRT3 and neoplasm: Interestingly, regarding to its inherent complexity, SIRT3 has been demonstrated to play the Janus role in cancer, indicating that SIRT3 activators or inhibitors would be utilized as anti-tumor agents in specific types of cancers, respectively.